A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Conditions: Ulcerative Colitis Interventions: Drug: TAK-279; Drug: Placebo Sponsors: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials